Cardlytics (Cardlytics) Total Stockholders Equity : $199.1 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Cardlytics Total Stockholders Equity?

Cardlytics's Total Stockholders Equity for the quarter that ended in Mar. 2024 was $199.1 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Cardlytics's Book Value per Share for the quarter that ended in Mar. 2024 was $4.13. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Cardlytics's Debt-to-Equity for the quarter that ended in Mar. 2024 was 1.34.

Cardlytics Total Stockholders Equity Historical Data

The historical data trend for Cardlytics's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cardlytics Total Stockholders Equity Chart

Cardlytics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

143.27

157.19

690.70

211.61

134.80

Cardlytics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															232.32	236.11	225.34	134.80	199.14

Cardlytics (NAS:CDLX) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Cardlytics's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(199.137	-	0)	/	48.174
	=	4.13

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Cardlytics's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2.079	+	265.546)	/	199.137
	=	1.34

Cardlytics Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Cardlytics's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Cardlytics (Cardlytics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Communication Services » Media - Diversified » Cardlytics Inc (NAS:CDLX) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

CYX:Germany

Address

675 Ponce de Leon Avenue NE, Suite 6000, Atlanta, GA, USA, 30308

Website

https://www.cardlytics.com

Cardlytics Inc operates an advertising platform within financial institutions' digital channels, which include online, mobile, email, and various real-time notifications. The company operates through three segments, Cardlytics Direct U.S. and U.K., and the Bridg platform. The Cardlytics Direct segment which generates the majority of revenue operates a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. The Bridg platform generates revenue through the sale of subscriptions to the cloud-based customer-data platform and the delivery of professional services like implementation, onboarding, and technical support. The company receives maximum revenue from the United States.

Executives

Clifford Sosin	10 percent owner	8 WRIGHT STREET, 1ST FL, WESTPORT CT 06880
Karim Saad Temsamani	director, officer: Chief Executive Officer	C/O CARDLYTICS, INC., 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308
Nicholas Hollmeyer Lynton	officer: Chief Legal & Privacy Officer	C/O CARDLYTICS, INC., 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308
Alex Mishurov	director	C/O CARDLYTICS, INC., 675 PONCE DE LEON AVE. NE, SUITE 6000, ATLANTA GA 30308
Scott A Hill	director	INTERCONTINENTALEXCHANGE, INC., 2100 RIVEREDGE PKWY. STE. 500, ATLANTA GA 30328
Alexis Desieno	officer: Chief Financial Officer	C/O CARDLYTICS, INC., 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308
Andrew Christiansen	officer: Chief Financial Officer	C/O CARDLYTICS, INC., 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308
Chris Suh	director	C/O CARDLYTICS, INC., 675 PONCE DE LEON AVE. NE, STE 6000, ATLANTA GA 30308
Jessica Jensen	director	C/O CARDLYTICS, INC., 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308
Amit Gupta	officer: Chief Operating Officer	C/O CARDLYTICS, INC, 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308
John V Balen	director
Scott D. Grimes	director, officer: Chief Executive Officer	CARDLYTICS, INC., 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308
Lynne Marie Laube	director, officer: Chief Operating Officer	C/O CARDLYTICS, INC., 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308
Kirk Somers	officer: Chief Legal & Privacy Officer
S Aimee Lapic	director	2101 WEBSTER ST #1650, OAKLAND CA 94612